THE PEOPLE
BOARD MEMBERS
Åge Nærdal
Trained as a Pharmacist having more than 35 years of experience in leadership from pharmaceutical industry.
Chairman
Stener Kvinnsland
Board Member
MD with a PhD in oncology. Various roles in the pharmaceutical an biotech industry, former COB at Oslo University Hospital, former MD of Helse Bergen and former Director at Haukeland University Hospital. Specialist and professor in cancer medicine.
Nalinava Sengupta
Co-founder
After 15 years of academic research in chemistry, turned entrepreneur for a mission.
Thomas Due
Board Member
He has over 20 years of Innovation and Venture Capital Fundraising experience in Norway. He has spent most of his adult life working where finance meets entrepreneurs.
Per Foss
Bio-organic chemistry doctorate having hugely diverse professional expertise in the industry.
ADVISORS
25 years of experience in drug development. Involved in more than 1000 projects involving clinical trials and regulatory affairs as a Clinical Research Organization executive chairman.
Knut Smerud
Espen Burum-Auensen
Medical doctor with a PhD in the field of oncology. Various roles in the pharmaceutical and biotech industry including business development, clinical trial development, commercial operations, and medical affairs
Co-founder and a senior scientist in Molecular Biology at Norwegian Air research Institure.
Co-founder
Tanima Sengupta
Ketil Wig
An expert in strategy and corporate finance advisory, has executed and negotiated hundreds of projects and transactions within strategy and M&A and restructurings / turnarounds.
Gokce Ataman
Financial Advisor, Senior finance professional with over 15 years of experience in M&A advisory and asset management.
Hilde Morris
Studied veterinary medicine and led international clinical development programs. Advices iNANOD for pre-clinical research, management, and corporate governance.
Jørn Lein-Mathisen
Business angel. Business development and entrepreneurial experiences internationally over 28 years.
Bruno Pirovino-Zuercher
Fund-raising Advisor
Finance Executive with over 25 years of experience in global LifeScience organisations and start/scale-up companies; Angel Investor
Hilde Nilsen
Professor in Department of Clinical Molecular Biology, Head (Epigenetics), Akershus University Hospital.